e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interval versus continuous cycling in advanced interstitial lung disease
L. Wickerson (Toronto, Canada), D. Brooks (Toronto, Canada), J. Granton (Toronto, Canada), L. Singer (Toronto, Canada), D. Rozenberg (Toronto, Canada), D. Reid (Toronto, Canada), S. Mathur (Toronto, Canada)
Source:
International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Session:
Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Session type:
Poster Discussion
Number:
3831
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Wickerson (Toronto, Canada), D. Brooks (Toronto, Canada), J. Granton (Toronto, Canada), L. Singer (Toronto, Canada), D. Rozenberg (Toronto, Canada), D. Reid (Toronto, Canada), S. Mathur (Toronto, Canada). Interval versus continuous cycling in advanced interstitial lung disease. 3831
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Interval versus continuous training in patients with end stage lung disease before lung transplantation
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009
Effects of a combination of pulmonary rehabilitation (PR) and non invasive ventilation (NIV) in patients with advanced interstitial lung disease (ILD)
Source: Annual Congress 2009 - Noninvasive ventilation in chronic respiratory failure
Year: 2009
Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD)
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009
Time as the fourth dimension of radiology: a patient with diffuse lung disease (interstitial lung disease)
Source: International Congress 2016 – GR2 Radiology
Year: 2016
Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group
Source: Eur Respir J 2005; 26: Suppl. 49, 500s
Year: 2005
Interval training as an alternative modality to continuous exercise in patients with COPD
Source: Eur Respir J 2002; 20: 12-19
Year: 2002
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
The relation of six-minute walk test and lung function in interstitial lung disease
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Estimating long-term survival in progressive fibrosing interstitial lung disease (PF-ILD) other than IPF using matched IPF data
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021
Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 215s
Year: 2004
Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment
Source: International Congress 2016 – IPF treatment I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept